LONG COVID-19

This study tested the antiviral drug Paxlovid in 964 adults with Long COVID to see if it could improve symptoms like brain fog, dizziness, and fatigue. Participants received either a short or longer course of Paxlovid or a placebo. The goal was to find out if clearing leftover vi…

This study tested different treatments for autonomic dysfunction, including POTS, in 381 adults with Long COVID. It compared non-drug approaches and medications to see which best eased symptoms like rapid heart rate and dizziness. The goal was to find practical options that can b…

This study tested different treatments to help people with Long COVID who struggle with exercise and feel very tired after activity. 660 adults took part across multiple medical centers. The goal was to see if these treatments could improve daily activity and quality of life.

This study tested different treatments to help people with Long COVID who struggle with exercise and feel worse after activity. About 300 adults joined the trial. Researchers measured changes in symptoms like tiredness and pain after exercise to see if the treatments helped impro…

This study tested a 9-week program combining group education and physical rehabilitation for people with Long COVID. 74 adults participated to see if the program could improve quality of life, mental well-being, and physical condition while reducing anxiety, depression, and fatig…

This study tested different treatments to help people with Long COVID who have sleep problems like extreme daytime sleepiness or trouble sleeping at night. Researchers enrolled 830 adults and used a flexible platform to compare multiple therapies. The goal was to find which treat…

This study tested whether ivabradine, a heart medication, can reduce symptoms like dizziness and rapid heart rate in people with long COVID. 181 adults took either ivabradine or a placebo. The goal was to see if the drug improves daily life and reduces uncomfortable symptoms.